BIO-TECHNE Corp (NASDAQ:TECH) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 04, 2026.
The Healthcare company reported Q0 revenue of .
BIO-TECHNE Corp's stock currently trades at $68.67 with a market capitalization of $9.4B.